Loading clinical trials...

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea | Clinical Trials | Clareo Health

RECRUITINGNA

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Effect of Fan Application in Preventing Ticagrelor-associated Dyspnea in Patients With Acute Coronary Syndrome.

NCT07268859•Acibadem University

Summary

This study will be conducted in the coronary intensive care unit of Dr. Siyami Ersek Chest, Heart and Vascular Surgery Training and Research Hospital. It aims to investigate the effect of hand fan therapy on ticagrelor-associated dyspnea in patients receiving ticagrelor.

Detailed Description

Patients in the coronary intensive care unit receiving ticagrelor and meeting the inclusion criteria will be included. The study includes two groups: a control group receiving standard care and an experimental group receiving standard care plus hand fan therapy. A total of 110 participants (55 per group) will be recruited. Randomization will be performed using a computer-based randomization program. Due to the nature of the intervention and sample characteristics, participants and the researcher will not be blinded. Data will be analyzed by a statistician not involved in the study, and the findings will be reported.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•Between the ages of 18 and 65,
•No severe hearing and vision problems,
•Can speak and understand Turkish,
•Easy to communicate with,
•First-time sufferer of acute coronary syndrome (ACS) for the first time,
•Decided to start ticagrelor therapy,
•Able to adapt to treatment,
•Individuals who volunteered to participate in the research.

Exclusion Criteria

•Having any problem that prevents you from communicating cognitively, emotionally and verbally,
•Obstructive sleep abnormalities,
•Have a disease that affects respiratory function (stage IV cancer, bronchial asthma, COVID-19, lung cancer, pulmonary edema, chronic obstructive pulmonary disease, pulmonary hypertension, pulmonary embolism, pneumonia or bronchitis, etc.),
•With metabolic abnormalities,
•Intubated after the procedure,
•Previously treated with ticagrelor,
•Individuals who did not volunteer to participate in the study. Losses to follow up
•Individuals who wish to leave the study voluntarily.
•Saturation value below 95%,
•The one with the arrest,
+2 more criteria

Locations (2)

İstanbul Üniversitesi-Cerrahapaşa

Istanbul, Avcılar, Turkey (Türkiye)

Sağlık Bilimleri Üniversitesi Dr. Siyami Ersek Göğüs Kalp ve Damar Cerrahisi Eğitim Araştırma Hastanesi

Istanbul, Üsküdar, Turkey (Türkiye)

Key Dates

Start Date

March 15, 2025

Primary Completion Date

January 10, 2026

Completion Date

January 30, 2026

Last Updated

December 8, 2025

Enrollment

110

ESTIMATED participants

Conditions

Acute Coronary SyndromesTicagrelorDyspnea

Interventions

STANDART CARE

OTHER

STANDART CARE & FAN THERAPY

OTHER

Contacts

Emine Tuğba YORULMAZ, research assistant

CONTACT

+905556177281 tugbayoorlmz@gmail.com

Arzu ERKOÇ, Associate professor

CONTACT

+905552735500 arzu.erkochut@iuc.edu.tr

Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.

NCT07429227

Acute Coronary Syndromes (ACS)

View study

RECRUITINGPHASE2

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

NCT05937854

Chronic Obstructive Pulmonary DiseasePulmonary Hypertension+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: December 8, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Effect of Fan Application in Preventing Ticagrelor-Associated Dyspnea

Inclusion Criteria

Exclusion Criteria

Evaluation Through Innovative Examinations of Intestinal Dysbiosis Status in Patients Diagnosed With Cardiovascular Diseases and Evaluation of the Efficacy of Natural and Probiotic Extracts in the Non-pharmacological Approach to Improving Intestinal Dysbiosis Status.

Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH

Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy

Drug-Eluting Balloon Treatment vs. Guideline-Directed Medical Therapy for the Treatment of Lipid-Rich Plaques

LUng and Cardiac Ultrasound for REspiratory Distress in ElDerly

Added Diagnostic Value of Point of Care Ultrasound in Acute Dyspnea